Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

United Health Products stock

UEEC
US91059D1000
A1W046

Price

0.13
Today +/-
+0.00
Today %
+0.08 %
P

United Health Products stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the United Health Products stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the United Health Products stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the United Health Products stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze United Health Products's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

United Health Products Stock Price History

DateUnited Health Products Price
10/1/20240.13 undefined
9/30/20240.13 undefined
9/27/20240.15 undefined
9/26/20240.14 undefined
9/25/20240.15 undefined
9/24/20240.13 undefined
9/23/20240.11 undefined
9/20/20240.13 undefined
9/19/20240.14 undefined
9/18/20240.14 undefined
9/17/20240.14 undefined
9/16/20240.15 undefined
9/13/20240.16 undefined
9/12/20240.16 undefined
9/11/20240.16 undefined
9/10/20240.16 undefined
9/9/20240.16 undefined
9/6/20240.17 undefined
9/5/20240.17 undefined
9/4/20240.18 undefined

United Health Products Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into United Health Products, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by United Health Products from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects United Health Products’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of United Health Products. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into United Health Products’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing United Health Products’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on United Health Products’s growth potential.

United Health Products Revenue, EBIT and net profit per share

DateUnited Health Products RevenueUnited Health Products EBITUnited Health Products Net Income
20230 undefined-2.43 M undefined-2.62 M undefined
202240,000 undefined-2.8 M undefined-1.69 M undefined
20210 undefined-29.81 M undefined-30.55 M undefined
20200 undefined-14.85 M undefined-15.71 M undefined
20190 undefined-6.09 M undefined-6.6 M undefined
201830,000 undefined-1.9 M undefined-5.4 M undefined
2017180,000 undefined-930,000 undefined-1.47 M undefined
2016240,000 undefined-520,000 undefined-540,000 undefined
201550,000 undefined-2.58 M undefined-2.59 M undefined
2014160,000 undefined-2.09 M undefined-2.14 M undefined
20130 undefined-1.32 M undefined-1.13 M undefined
20120 undefined-210,000 undefined-280,000 undefined
20110 undefined-1.32 M undefined-1.59 M undefined

United Health Products Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2011201220132014201520162017201820192020202120222023
0000000000000
-------------
-------------
0000000000000
-10-1-2-200-1-6-14-29-2-2
-------------
-10-1-2-20-1-5-6-15-30-1-2
---100.00---400.0020.00150.00100.00-96.67100.00
80.8583.3794.4102.95138.68152.1155.83172.12175.88183.76225.74229.72239.08
-------------
Details

Keystats

ⓘ

Revenue and Growth

The United Health Products Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the United Health Products is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (k)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (k)CURRENT ASSETS (k)TANGIBLE ASSETS (k)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (k)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (k)TOTAL ASSETS (k)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (k)DEBT (M)TOTAL CAPITAL (k)
2011201220132014201520162017201820192020202120222023
                         
00010030190302050201095.42
0000101100000000
0000000000000
00303040604030807003033.6
000000105000102022.8
003040502002401101001203060151.82
0000000001000076.52
0000000000000
0000000000000
25015050000000004032.4
0000000000000
0000000000024023.9
250150500000001000280132.82
25015080405020024011010022030340284.64
                         
8080100110150150170170180190230230244.78
4.514.626.37.6111.1711.8913.4119.225.0540.771.0271.8374.74
-6.12-6.4-7.52-9.67-12.26-12.8-14.12-19.53-26.13-41.84-72.39-74.08-76.7
000340140000000-500
0000000000000
-1.53-1.7-1.12-1.61-0.8-0.76-0.54-0.16-0.9-0.95-1.14-2.07-1.71
0.710.770.290.370.420.480.180.150.510.420.831.260.99
00000011040120190120470255.31
5505001605701501500000000
52057076071029033051070370560220690707.5
0000000000000
1.781.841.211.650.860.960.80.2611.171.172.421.95
0000000000000
0000000000000
00000000000048.49
00000000000048.49
1.781.841.211.650.860.960.80.2611.171.172.422
25014090406020026010010022030350284.64
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of United Health Products provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand United Health Products's financial health and stability.

Assets

United Health Products's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that United Health Products must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of United Health Products after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into United Health Products's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (k)CASH FLOW FROM FINANCING ACTIVITIES (k)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201120122013201420152016201720182019202020212022
-10-1-2-20-1-5-6-15-30-1
000000000000
000000000000
00000000001,0001,000
00011004413280
000000000000
000000000000
0000000-1-1-100
000000000000
000000000000
000000000000
000000000000
000000000000
00000001,0001,0001,00000
00000001,0001,0001,00000
------------
000000000000
000000000000
-0.280-0.12-0.33-0.84-0.47-0.65-1.28-1.77-1.43-0.83-0.66
000000000000

United Health Products stock margins

The United Health Products margin analysis displays the gross margin, EBIT margin, as well as the profit margin of United Health Products. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for United Health Products.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the United Health Products's sales revenue. A higher gross margin percentage indicates that the United Health Products retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the United Health Products's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the United Health Products's total revenue generated. When comparing the revenue margin year over year, investors can gauge the United Health Products's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the United Health Products. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the United Health Products's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

United Health Products Margin History

United Health Products Gross marginUnited Health Products Profit marginUnited Health Products EBIT marginUnited Health Products Profit margin
202350 %0 %0 %
202250 %-7,000 %-4,225 %
202150 %0 %0 %
202050 %0 %0 %
201950 %0 %0 %
201833.33 %-6,333.33 %-18,000 %
201744.44 %-516.67 %-816.67 %
201650 %-216.67 %-225 %
201560 %-5,160 %-5,180 %
201450 %-1,306.25 %-1,337.5 %
201350 %0 %0 %
201250 %0 %0 %
201150 %0 %0 %

United Health Products Stock Sales Revenue, EBIT, Earnings per Share

The United Health Products earnings per share therefore indicates how much revenue United Health Products has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue United Health Products earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates United Health Products's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of United Health Products’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating United Health Products's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

United Health Products Revenue, EBIT and net profit per share

DateUnited Health Products Sales per ShareUnited Health Products EBIT per shareUnited Health Products Earnings per Share
20230 undefined-0.01 undefined-0.01 undefined
20220 undefined-0.01 undefined-0.01 undefined
20210 undefined-0.13 undefined-0.14 undefined
20200 undefined-0.08 undefined-0.09 undefined
20190 undefined-0.03 undefined-0.04 undefined
20180 undefined-0.01 undefined-0.03 undefined
20170 undefined-0.01 undefined-0.01 undefined
20160 undefined-0 undefined-0 undefined
20150 undefined-0.02 undefined-0.02 undefined
20140 undefined-0.02 undefined-0.02 undefined
20130 undefined-0.01 undefined-0.01 undefined
20120 undefined-0 undefined-0 undefined
20110 undefined-0.02 undefined-0.02 undefined

United Health Products business model

United Health Products Inc is an American company that specializes in the development, manufacturing, and distribution of surgical wound dressings. The company was founded in 1997 and is headquartered in Westbury, New York. United Health Products is one of the most popular companies on Eulerpool.com.

United Health Products SWOT Analysis

Strengths

United Health Products Inc (UHPI) has several strengths that contribute to its competitive advantage and market position. Firstly, the company specializes in manufacturing and distributing wound care products, which provides a focused and specialized approach to this particular market segment. This expertise allows UHPI to develop innovative and high-quality products that meet the specific needs of healthcare professionals and patients. Secondly, UHPI has established strong partnerships and collaborations with key stakeholders in the healthcare industry, including hospitals, clinics, and healthcare suppliers. These partnerships enhance UHPI's distribution capabilities and enable the company to reach a wide customer base, both domestically and internationally. Additionally, UHPI's products have been granted FDA clearances, which provide assurance to customers regarding the safety and efficacy of the products. This regulatory approval differentiates UHPI from competitors and enhances its credibility in the marketplace.

Weaknesses

Despite its strengths, UHPI also faces certain weaknesses that could potentially hinder its growth and market performance. One weakness is the company's relatively small size and limited resources compared to larger competitors in the industry. This can pose challenges in terms of scalability, marketing budget, and research and development capabilities. Additionally, UHPI may face difficulty in penetrating highly competitive markets where established competitors already have strong brand recognition and customer loyalty. Building brand awareness and gaining market share in such environments can be a major challenge for the company.

Opportunities

There are several opportunities that UHPI can capitalize on to further its growth and expand its market presence. One opportunity lies in the increasing demand for advanced wound care products, as the aging population and rising prevalence of chronic diseases drive the need for effective wound management solutions. UHPI can leverage its expertise and product innovation to tap into this growing market and gain a competitive advantage. Furthermore, UHPI can explore strategic partnerships and collaborations with healthcare institutions and organizations to expand its distribution network and enhance market penetration. By aligning with key stakeholders, UHPI can access new customer segments and geographies, increasing its market reach.

Threats

UHPI faces certain threats that could impact its business operations and market position. One major threat is the presence of substitute products and alternative treatments for wound care. These substitutes may offer similar therapeutic benefits at lower costs or with different delivery mechanisms, potentially reducing the demand for UHPI's products. Additionally, regulatory changes and compliance requirements in the healthcare industry can pose threats to UHPI. Changes in government regulations or reimbursement policies can impact the pricing and accessibility of UHPI's products, affecting the company's financial performance.

United Health Products Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

United Health Products historical P/E ratio, EBIT multiple, and P/S ratio

United Health Products shares outstanding

The number of shares was United Health Products in 2023 — This indicates how many shares 239.08 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue United Health Products earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates United Health Products's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of United Health Products’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating United Health Products's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for United Health Products.

United Health Products shareholders

%
Name
Stocks
Change
Date
7.24550 % Beplate (Douglas K)18,000,00004/1/2024
0.73008 % Heaton (Kristofer)1,813,729257,8134/1/2024
0.62392 % Denser (Robert J)1,550,00004/1/2024
0.42453 % Thom (Brian David)1,054,671125,0004/1/2024
0.06517 % SlateStone Wealth, LLC161,905012/31/2023
1

United Health Products Executives and Management Board

Mr. Brian Thom57
United Health Products Chief Executive Officer, Director (since 2020)
Compensation 238,500
Mr. Louis Schiliro52
United Health Products Treasurer, Company Secretary (since 2018)
Compensation 238,500
Mr. Kristofer Heaton44
United Health Products Principal Financial Officer, Vice President - Finance
Compensation 198,750
Mr. Robert Denser52
United Health Products Independent Director
1

Most common questions regarding United Health Products

What values and corporate philosophy does United Health Products represent?

United Health Products Inc represents values of innovation, quality, and patient safety. They are committed to creating and delivering cutting-edge medical products that improve patient outcomes. With a focus on developing advanced wound care solutions, United Health Products Inc prioritizes research and development to provide clinicians with effective tools for healing and treating wounds. Their corporate philosophy revolves around integrity, transparency, and collaboration, ensuring that the needs of healthcare providers and patients are met with the utmost dedication. By consistently delivering exceptional products, United Health Products Inc aims to contribute to the overall improvement of global healthcare.

In which countries and regions is United Health Products primarily present?

United Health Products Inc is primarily present in the United States.

What significant milestones has the company United Health Products achieved?

United Health Products Inc has achieved several significant milestones. Firstly, the company successfully developed and commercialized HemoStyp®, a patented, plant-based hemostatic agent, that offers superior control over bleeding and improves patient outcomes. Additionally, United Health Products Inc has expanded its product line to include HemoStyp® Gauze, a uniquely advanced dressing for wound care. The company has established itself as a leader in the healthcare industry with its innovative solutions and has demonstrated consistent growth. United Health Products Inc continues to strive for excellence in medical products and is committed to enhancing patient care and safety.

What is the history and background of the company United Health Products?

United Health Products Inc. is a company that specializes in the development and manufacture of wound care products. Established in 1996, United Health Products has a rich history of innovation and has become a leading provider of advanced wound care solutions. With a strong focus on research and development, the company has successfully introduced groundbreaking technologies like HemoStyp, a patented hemostatic gauze that aids in the rapid control of bleeding. United Health Products Inc. is committed to improving patient outcomes and is dedicated to delivering quality wound care products that make a meaningful difference in people's lives.

Who are the main competitors of United Health Products in the market?

Some of the main competitors of United Health Products Inc in the market include Johnson & Johnson, Medtronic, and 3M Company.

In which industries is United Health Products primarily active?

United Health Products Inc primarily operates in the healthcare industry.

What is the business model of United Health Products?

The business model of United Health Products Inc. focuses on the development, manufacturing, and marketing of innovative technologies and products for the healthcare industry. As a company, United Health Products Inc. aims to provide effective medical solutions that enhance patient outcomes and improve healthcare practices. Their product portfolio includes HemoStyp®, a patented hemostatic gauze that aids in the control of bleeding, offering a cost-effective and versatile alternative to traditional methods. United Health Products Inc. strives to address the needs of healthcare professionals, offering advanced solutions that contribute to better patient care.

What is the P/E ratio of United Health Products 2024?

The P/E ratio cannot be calculated for United Health Products at the moment.

What is the P/S ratio of United Health Products 2024?

The P/S cannot be calculated for United Health Products currently.

What is the AlleAktien quality score of United Health Products?

The AlleAktien quality score for United Health Products is 4/10.

What is the revenue of United Health Products 2024?

The revenue cannot currently be calculated for United Health Products.

How high is the profit of United Health Products 2024?

The profit cannot currently be calculated for United Health Products.

What is the business model of United Health Products

United Health Products Inc. is one of the most innovative companies in the medical industry. The New York City-based company offers a wide range of products specializing in wound care and hemostasis. The company is divided into several divisions. One of them is the HemaQuell SP product line, which includes a range of sterile wound dressings for the treatment of mild to severe bleeding. HemaQuell SP is made from a patented hydrophilic gel composite material that is free from chemicals, dyes, and synthetic fibers. Another division of United Health Products is the ChitoGauze XR PRO compression bandage. The product line is able to quickly and effectively stop bleeding by promoting blood clotting. The bandage consists of a combination of natural chitosan and hydrogel fibers, which provide a soft and flexible dressing material. Another product from United Health Products is the ChitoGauze product. It is a compression bandage based on chitosan. The bandage is able to immediately stop bleeding and treat wounds. The product is available in various sizes and is suitable for a variety of applications. Among the products of United Health Products, you will also find the ChitoVan product. ChitoVan is an antiviral and antibacterial technology that is integrated into a variety of products. It can be used as an additive in textiles, papers, and plastics. This technology kills viruses and bacteria, reducing infections and the transmission of diseases. Over the years, United Health Products has formed partnerships with leading medical institutions, hospitals, and retailers to sell its products. The company also works closely with government agencies to deploy its high-quality products in emergencies. United Health Products' business model is focused on meeting the needs of its customers. The company offers its products at a competitive price without compromising on quality. The company also utilizes modern technologies to improve its production processes and increase efficiency. United Health Products is committed to constantly improving and expanding its products to meet the needs of the healthcare sector. The company is constantly working on new research and development projects to improve the effectiveness and efficiency of its products. Overall, United Health Products is the perfect choice for those who value quality and reliability in the treatment of wounds and bleeding. The company has made a name for itself and has made its mark in the medical industry.

What is the United Health Products dividend?

United Health Products pays a dividend of 0 USD distributed over payouts per year.

How often does United Health Products pay dividends?

The dividend cannot currently be calculated for United Health Products or the company does not pay out a dividend.

What is the United Health Products ISIN?

The ISIN of United Health Products is US91059D1000.

What is the United Health Products WKN?

The WKN of United Health Products is A1W046.

What is the United Health Products ticker?

The ticker of United Health Products is UEEC.

How much dividend does United Health Products pay?

Over the past 12 months, United Health Products paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, United Health Products is expected to pay a dividend of 0 USD.

What is the dividend yield of United Health Products?

The current dividend yield of United Health Products is .

When does United Health Products pay dividends?

United Health Products pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of United Health Products?

United Health Products paid dividends every year for the past 0 years.

What is the dividend of United Health Products?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is United Health Products located?

United Health Products is assigned to the 'Health' sector.

Wann musste ich die Aktien von United Health Products kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of United Health Products from 10/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did United Health Products pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of United Health Products in the year 2023?

In the year 2023, United Health Products distributed 0 USD as dividends.

In which currency does United Health Products pay out the dividend?

The dividends of United Health Products are distributed in USD.

All fundamentals about United Health Products

Our stock analysis for United Health Products Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of United Health Products Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.